BC
BIO icon

Brookfield Corp’s Bio-Rad Laboratories Class A BIO Stock Holding History

Brookfield Corp’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,243
Closed -$615K – 640
2022
Q2 		$615K Buy
+1,243
New +$647K ﹤0.01% 533

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Brookfield Corp's BIO Position: Q3 2022 in Review

Brookfield Corp sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2022, closing a stake of 1,243 shares — an estimated $615K sold.

Brookfield Corp first reported a position in BIO in Q2 2022 and held it in 1 quarter. The position peaked at $615K in Q2 2022. 484 funds tracked by Wall St. Rank hold BIO as of Q3 2022.

  • Brookfield Corp reported no remaining Bio-Rad Laboratories Class A position as of Q3 2022 after selling out during the quarter.
  • Brookfield Corp sold 1,243 Bio-Rad Laboratories Class A shares in Q3 2022, an estimated $615K.
  • Brookfield Corp first reported a position in Bio-Rad Laboratories Class A in Q2 2022 and held it in 1 quarter.
  • Brookfield Corp's Bio-Rad Laboratories Class A position peaked at $615K in Q2 2022.
  • 484 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2022.

Based on Brookfield Corp's 13F filing for Q3 2022, filed 14 Nov 2022.